Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018.
The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.
Company Details
- Employees
- 77
- Founded
- -
- Address
- 3f, Building 2, No.88, Jiangling Road, Binjiang District, Hangzhou, China, Hangzhou,zhejiang,china
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.venusmedtech.com/
- HQ
- Hangzhou, Zhejiang
Venus Medtech Questions
Venus Medtech's website is http://www.venusmedtech.com/
Venus Medtech's LinkedIn profile is https://cn.linkedin.com/company/venusmedtech
Venus Medtech has
77 employees.
View email and phone details for 77
employees at Venus Medtech.
Venus Medtech's industry is
Medical Equipment Manufacturing
Venus Medtech's top competitors are
Pi-Cardia,
Protembis Gmbh,
Medtronic,
Colibri Heart Valve,
Venus Medtech International,
Anteris Technologies,
Valtech Cardio,
Valve Medical,
Filterlex Medical Ltd.,
Venus Medtech Europe.
Venus Medtech's categories are Medical Equipment Manufacturing
Venus Medtech's founding year is 2009
